Does Upgraded CROX Forecasts and DCF Undervaluation Change The Bull Case For Crocs (CROX)?

• In recent months, Crocs has seen analysts lift their full-year earnings forecasts and assign it a favorable Zacks Rank #2 (Buy), reflecting stronger sentiment toward its profitability outlook.
• Alongside this, independent valuation work using a Discounted Cash Flow model suggests Crocs’ shares may trade below estimated intrinsic value, drawing attention to the durability of demand for its clogs and newer lines.
• With analyst earnings estimates moving higher, we’ll now examine how this improving outlook could influence Crocs’ existing investment narrative and risks.

Find 46 companies with promising cash flow potential yet trading below their fair value.

Crocs Investment Narrative Recap

To own Crocs today, you need to believe its global brand strength, product innovation and direct to consumer shift can overcome near term earnings volatility and fashion risk. The recent uptick in analyst earnings estimates and a favorable Zacks Rank improve sentiment but do not materially change the near term catalyst, which is a return to consistent profitability after a loss making 2025, or the key risk around sustained demand for clogs and HEYDUDE.

The most relevant recent development here is Crocs’ 2025 earnings release and 2026 guidance, which pointed to a swing from strong profit in 2024 to a net loss in 2025 and guided 2026 revenue to be roughly flat year on year. Against that backdrop, higher analyst earnings estimates and suggestions that the shares trade below estimated intrinsic value sit in clear tension with management’s own cautious outlook, keeping execution and margin recovery firmly in focus.

Yet investors should also weigh how fashion cyclicality and HEYDUDE’s ongoing wholesale and inventory challenges could affect Crocs’ earnings power and are issues investors should be aware of...

Read the full narrative on Crocs (it's free!)

Crocs’ narrative projects $4.0 billion revenue and $925.2 million earnings by 2028. This implies a 1.0% yearly revenue decline but a roughly $688.7 million earnings increase from $236.5 million today.

Uncover how Crocs' forecasts yield a $102.91 fair value, a 18% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were previously assuming earnings could reach about US$738.3 million by 2028, yet rising tariffs and inventory costs remind you that projections like these can differ sharply from reality and may need revisiting after Crocs’ latest guidance.

Explore 13 other fair value estimates on Crocs - why the stock might be worth 14% less than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Crocs research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Crocs research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Crocs' overall financial health at a glance.

Contemplating Other Strategies?

Our top stock finds are flying under the radar-for now. Get in early:

• Outshine the giants: these 19 early-stage AI stocks could fund your retirement.
• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 32 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com